Trial Profile
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 21 Feb 2020
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Braeburn Pharmaceuticals
- 04 Dec 2018 Status changed from active, no longer recruiting to discontinued.
- 26 Apr 2017 Results published in a Braeburn Pharmaceuticals media release.
- 07 Oct 2016 Status changed from recruiting to active, no longer recruiting.